Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6Neoplasms 3Small Cell Lung Carcinoma 2Recurrence 2Lymphoma 2Non-Erosive Reflux Disease 1Melanoma 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hematologic Neoplasms 1Helicobacter Infections 1Gastrointestinal Hemorrhage 1Gastroesophageal Reflux 1Gastritis, Atrophic 1Dyspepsia 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Barrett Esophagus 1Atrophy 1Advanced Solid Tumors 1Advanced Solid Malignancies 1Adenocarcinoma 1Acrocephalosyndactylia 1

Interventions

Bismuth 5Amoxicillin 4Tetracycline 3Esomeprazole 3Clarithromycin 3Furazolidone 2Rabeprazole 1Minocycline 1Berberine 11-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dyspepsia × Rabeprazole × Clear all
NCT04697186 2023-01-31

Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
524 enrolled
Gastrointestinal

Dyspepsia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡